Robert Mayfield, MD
Family Medicine · Midlothian, VANPI 1528010097
Payments from drug & device makers
Across 200 payments — averaging $18.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$569
- AstraZeneca$517
- Novo Nordisk$484
- Lilly USA, LLC$387
- Pfizer$270
- Abbott$169
- plus $1K from 27 others
What the payments were for
- Food & beverage$3,723100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 37 | $569 |
| AstraZeneca | 24 | $517 |
| Novo Nordisk | 28 | $484 |
| Lilly USA, LLC | 20 | $387 |
| Pfizer | 15 | $270 |
| Abbott | 9 | $169 |
| Boston Scientific | 5 | $144 |
| Amgen | 8 | $134 |
| Boehringer Ingelheim | 6 | $101 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $94 |
| GSK | 5 | $86 |
| Exact Sciences | 4 | $83 |
| Inspire Medical Systems, Inc. | 3 | $81 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $68 |
| Merck | 3 | $59 |
| Insightec,inc | 1 | $57 |
| Dexcom, Inc. | 3 | $51 |
| C2n Diagnostics, LLC | 1 | $38 |
| Edwards Lifesciences | 2 | $33 |
| Phathom Pharmaceuticals, Inc. | 2 | $31 |
| Bayer | 2 | $30 |
| Astellas Pharma US Inc | 2 | $29 |
| Dynavax Technologies Corporation | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| Amneal Pharmaceuticals LLC | 1 | $22 |
| Eisai Inc. | 1 | $19 |
| Philips North America LLC | 1 | $19 |
| Viatris Specialty LLC | 1 | $19 |
| Cequr Corporation | 1 | $18 |
| Watermark Medical, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $14 |
| Shire North American Group Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$125
How this compares
$3,723 in reported general payments places this provider in the 85th percentile of 2,553 family medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 57 | $77,193 |
| OzempicSemaglutide | 57 | $66,229 |
| EliquisApixaban | 60 | $62,836 |
| JardianceEmpagliflozin | 40 | $56,948 |
| FarxigaDapagliflozin Propanediol | 52 | $53,693 |
| XareltoRivaroxaban | 41 | $40,279 |
| JanuviaSitagliptin Phosphate | 38 | $38,940 |
| MyrbetriqMirabegron | 39 | $27,840 |
| JanumetSitagliptin Phos/Metformin Hcl | 16 | $20,322 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 31 | $18,874 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $15,911 |
| TradjentaLinagliptin | 15 | $12,327 |
| BrilintaTicagrelor | 13 | $11,806 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $11,115 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 54 | $9,891 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere, Brilinta | $517 | $81,41178 claims |
| Lilly USA, LLCMounjaro | $387 | $77,19357 claims |
| Boehringer IngelheimJardiance, Tradjenta | $101 | $69,27655 claims |
| Novo NordiskOzempic | $484 | $66,22957 claims |
| PfizerEliquis | $270 | $62,83660 claims |
| MerckJanuvia, Janumet | $59 | $59,26354 claims |
| GSKAnoro Ellipta, Breo Ellipta, Trelegy Ellipta | $86 | $36,26162 claims |
| Astellas Pharma US IncMyrbetriq | $29 | $27,84039 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $22 | $5,129440 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,553 family medicine providers in Virginia.
Other family medicine in Midlothian
- Aaron HartmanMidlothian$17.4M
- Jennifer BrownMidlothian$1.3M
- John ScottGlen Allen$16.7M
- Banu MyneniPortsmouth$12.8M
- Patricia HouserWinchester$3.5M
- Stephan JannachDanville$3M
- Linda SchneiderHampton$2.1M
- Brian McCormickHampton$793K
- Jerome DanielNorth Chesterfield$779K
- Samir AbdelshaheedChesapeake$642K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.